Table 2.
Comparison of demographic factors, disease severity and characteristics and gastrointestinal symptoms among Group I (Mini Nutritional Assessment <23.5) and Group II (Mini Nutritional Assessment >24)
| PD group | Group I (43) | Group II (32) | P |
|---|---|---|---|
| Age (years) | 64+9.5 | 62+10.5 | 0.54 |
| Gender (male) | 27 (62.7%) | 20 (62.5%) | 0.903 |
| Duration of disease (years) | 5.19+3.5 | 5.03+3.7 | 0.743 |
| H&Y<3 | 11 (25.5%) | 18 (56.5%) | 0.009 |
| H&Y>3 | 32 (74.4%) | 11 (34.3%) | |
| LED | 585.91 | 512.21 | 0.431 |
| Falls (> 2 III UPDRS-13) | 12 | 2 | 0.0374 |
| Constipation | 31 (72.1%) | 9 (28.1%) | 0.0004 |
| Dysphasia | 22 (51.2%) | 4 (11.7%) | 0.0008 |
| Silarrhoea | 22 (51.2%) | 9 (28.1%) | 0.041 |
PD=Parkinson’s disease, LED=Levodopa equivalent dose, UPDRS=Unified Parkinson’s Disease Rating Scale